Reducing injection burden has long been a priority in diabetes care. Now, a weekly, fixed-dose combination of basal insulin and a GLP-1 receptor agonist is one step closer to approval in Europe.

Weight Loss Medications Available Online If you’re eligible for weight loss medication, there are a fair number of options.

Novo Nordisk, the Denmark based pharma giant, has finally launched its hugely popular diabetes and weight-loss medicine, Ozempic, in the Indian market. Ozempic has recently garnered global recognition ...

The GLP-1 receptor agonist is approved in India as an adjunct to diet and exercise for adults with type 2 diabetes ...

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.

The pre-filled pen, which consists of four doses of 0.25mg injection required for initiation, costs Rs.8800 per month (Rs,2200 per week), 0.5 mg per month costs Rs.10,170 (Rs.2542.5 per week) and 1mg ...